BioPharmSignal logoBioPharmSignal

Biotech News

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical (XTNT)Xtant MedicalCompany update

Xtant has hired Dilon's U.S. sales team to assist in selling the HEMOBLAST ® Bellows product and penetrating the estimated $2.0 billion global addressable market for hemostatic products BELGRADE, Mont. and NEWPORT NEWS, Va., April 13, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE

Open original release

Related news

XTNTXtant Medical2026-04-09 12:00 EST

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

XTNTXtant Medical2026-03-25 12:00 EST

Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026

TCMDTactile Systems Technology, Inc.2026-07-13 12:00 EST

Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients

SGHTSight Sciences2026-04-01 20:05 EST

Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

AORTArtivion2026-04-23 20:15 EST

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results

View all latest news

Xtant Medical

Xtant Medical is a spinal and biologics medical device company focused on bone grafts, biologics, and reconstructive products. Its business is centered on procedure-linked orthopedic care.

Recent company news

XTNTXtant Medical2026-05-13 11:00 EST

Xtant Medical Reports First Quarter 2026 Financial Results

XTNTXtant Medical2026-05-07 12:00 EST

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

XTNTXtant Medical2026-05-06 12:00 EST

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

XTNTXtant Medical2026-04-13 13:04 EST

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

XTNTXtant Medical2026-04-09 12:00 EST

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

Stock data

Close
0.44 USD
Market cap
65.22M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States